发明名称 |
Dual variable domain immunoglobulins and uses thereof |
摘要 |
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease. |
申请公布号 |
US9109026(B2) |
申请公布日期 |
2015.08.18 |
申请号 |
US200912477668 |
申请日期 |
2009.06.03 |
申请人 |
ABBVIE, INC. |
发明人 |
Ghayur Tariq;Hahn Alfred;Mueller Bernhard |
分类号 |
C07K16/00;C12P21/08;C07H21/04;C12P21/04;C12N5/16;C12N1/20;C12N15/00;A61K39/395;A61K39/40;C07K16/22;C07K16/18;C07K16/24;C07K16/28;C07K1/00 |
主分类号 |
C07K16/00 |
代理机构 |
Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. |
代理人 |
Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. |
主权项 |
1. A binding protein comprising first and second polypeptide chains, each independently comprising VD1-(X1)n-VD2-C-(X2)n, wherein
VD1 is a first variable domain; VD2 is a second variable domain; C is a constant domain; X1 is a linker; X2 is an Fc region; n is 0 or 1, wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding Tumor Necrosis Factor a (TNF-α) and Receptor for Advanced Glycation Endproducts (RAGE), wherein the first and second polypeptide chains of the binding protein comprise: a. SEQ ID NO: 154 and SEQ ID NO: 155, or b. SEQ ID NO: 156 and SEQ ID NO: 157. |
地址 |
North Chicago IL US |